The lateral septum is heavily implicated in anxiety regulation, with lesions or pharmacological inhibition of this region suppressing rats' defensive responses in various rat models of anxiety. My first objective was to explore the functional relationship between the lateral septum and its major afferent structure, the ventral hippocampus. Although these structures are extensively connected, it was not clear if they work in concert to regulate anxiety-like behaviours. This idea was tested using a pharmacological disconnection technique, whereby communication between these two structures was disabled by infusing the GABAA agonist muscimol into one side of the lateral septum and the contralateral side of the ventral hippocampus. Increases in open-arm exploration were evident when muscimol was co-infused into one side of the lateral septum and the contralateral ventral hippocampus. By contrast, open arm exploration was not altered when muscimol was co-infused into one side of the lateral septum and the ipsilateral ventral hippocampus. These results support the contention that the ventral hippocampus and the lateral septum regulate rats' open arm exploration in a serial fashion, and that this involves ipsilateral projections from the former to the latter site. My second objective was to further characterize the neuropharmacological aspects of lateral septal regulation of behavioural defence. The lateral septum contains high levels of NPY Y1 and Y2 receptor binding sites in the brain, yet little is known about their contribution in anxiety regulation at this site. Therefore, the second aim of my thesis was to characterize the contribution of NPY and its Y1 and Y2 receptor subtypes in the lateral septal regulation of anxiety in the elevated plus maze, novelty-induced suppression of feeding, and shock-probe burying tests. I determined that distinct NPY receptors differentially contribute to NPY-mediated anxiolysis in a test specific manner, with the Y1 receptor mediating NPY-induced anxiolysis in the novelty-induced suppression of feeding test, and the Y2 receptor mediating NPY13-36-induced anxiolysis in the plus-maze test. Taken together, the results from these studies reinforce the view that the regulation of anxiety involves a variety of different, yet overlapping neural processes. / Thesis (Ph.D, Neuroscience Studies) -- Queen's University, 2012-09-25 18:02:11.172

No description available.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2002. / Härtill 5 uppsatser.

Thesis (Ph. D.)--University of Missouri-Columbia, 2008. / "May 2008" The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Vita. Includes bibliographical references.

Thesis (Ph. D.)--University of Missouri-Columbia, 1997. / Typescript. Vita. Includes bibliographical references (leaves 70-82). Also available on the Internet.

Thesis (Ph. D.)--University of Washington, 1998. / Vita. Includes bibliographical references (leaves [42]-50).

Thesis (Ph. D.)--University of Missouri-Columbia, 1997. / Typescript. Vita. Includes bibliographical references (leaves 70-82). Also available on the Internet.

Thesis (Ph. D.)--University of Chicago, Department of Neurobiology, Pharmacology, and Physiology, June 2000. / Includes bibliographical references. Also available on the Internet.

Understanding the central nervous systems role in appetite regulation is crucial to cure the obesity epidemic, which is more prevalent than any disease in the United States. Central appetite regulators, known as neuropeptides, are pivotal in understanding appetite regulation. Neuropeptide Y (NPY), a 36 amino acid peptide, plays a major role in regulating the hunger signals from the brain. In all vertebrates studied, it is a strong orexigenic neurotransmitter located throughout multiple nuclei of the hypothalamus. Peripheral hormones associated with hunger are able to activate NPY neurons in the arcuate nucleus, which leads to a cascade of events that activate orexigenic neurons throughout the hypothalamus. Although extensive research has gone into understanding the role of NPY in appetite regulation, the effects of macronutrient composition of diets on NPY function have not been elucidated in non-mammalian species. This research investigates how food intake is affected by dietary macronutrient composition in broiler type chickens that are fed three varying macronutrient diets: high carbohydrate (22% CP, 3000kcal/kg) a broiler starter diet, high fat (60% ME from lard), high protein 30%CP). All diets were formulated to be isocaloric. When chicks are fed the high fat diet central NPY administration has a greater effect on feed intake compared to both the basal and high protein diet. Regardless of what diet the chick is fed from hatch, if they are switched to one of the other two diets post central administration of NPY the high fat diet stimulated feed intake for the longest duration. Although, NPY had the strongest orexigenic effect on chicks fed the high fat diet, in a choice diet situation broiler chicks chose the high protein diet, independent of central NPY administration. / Master of Science

Peptides that regulate feeding behavior via the brain may also regulate energy storage and expenditure in the adipose tissue, a system collectively known as the "brain-fat axis". Neuropeptide Y (NPY) is orexigenic and promotes adipogenesis in both birds and mammals, although mechanisms in adipose tissue are unclear. The first objective was thus to evaluate effects of NPY on chick preadipocyte proliferation and differentiation. Preadipocytes were treated with NPY and gene expression and cellular proliferation were evaluated. Cells were also treated with NPY during differentiation and harvested during the later stages. With increased gene expression of proliferation markers in preadipocytes, and during differentiation increased expression of adipogenesis-associated factors, increased lipid accumulation, and increased activity of an adipogenic enzyme, glycerol-3-phosphate dehydrogenase, results suggest that NPY may enhance preadipocyte activity and adipogenesis and promotes lipid accumulation throughout chicken adipocyte differentiation. Another appetite-regulatory peptide, alpha-melanocyte stimulating hormone (α-MSH), is anorexigenic and mediates lipolysis in adipose tissue, but effects on fat in avians are unreported. The second objective was thus to determine the effects of exogenous α-MSH on adipose tissue physiology in broiler chicks. Chicks were intraperitoneally injected with α-MSH and adipose tissue and plasma collected. Cells isolated from abdominal fat of a different set of chicks were treated with α-MSH. Results suggest that α-MSH increases lipolysis and reduces adipogenesis in chick adipose tissue. Collectively, results of this research provide insights on how appetite-regulatory peptides like NPY and α-MSH affect adipose tissue physiology, thereby playing important roles in regulating whole-body energy balance. / Master of Science / Peptides that contribute to feeding behavior via the brain may also affect the way energy is stored and released in the adipose tissue. Neuropeptide Y (NPY) is a neurotransmitter that induces hunger, and promotes the growth of adipose tissue in both birds and mammals, although mechanisms in adipose tissue are unclear. The first objective was thus to evaluate effects of NPY on chick preadipocyte activity and the process by which preadipocyte cells differentiate into fully matures adipocytes, a process termed adipogenesis. Preadipocytes were treated with NPY and gene expression and cellular division were evaluated. Cells were also treated with NPY during differentiation and harvested during the later stages. With increased activity in preadipocytes, and during differentiation greater activity leading to increased fat accumulation, results suggest that NPY may enhance preadipocyte activity and adipogenesis and promotes fat accumulation throughout chicken adipocyte differentiation. Another appetite-regulatory peptide, alpha-melanocyte stimulating hormone (α-MSH), inhibits hunger and breaks down adipose tissue, but effects on fat in avians are unreported. The second objective was thus to determine the effects of α-MSH on adipose tissue physiology in chicks. Chicks were injected with α-MSH and cells isolated from abdominal fat of a different set of chicks were treated with α-MSH. Results suggest that α-MSH breaks down fat and reduces adipogenesis in chick adipose tissue. Collectively, results of this research provide insights on how NPY and α-MSH affect adipose tissue physiology, thereby playing important roles in regulating whole-body energy balance.